SNDL Inc
F:VY4

Watchlist Manager
SNDL Inc Logo
SNDL Inc
F:VY4
Watchlist
Price: 1.864 EUR 3.21% Market Closed
Market Cap: 492.6m EUR

EV/EBIT
Enterprise Value to EBIT

-56.8
Current
-12.9
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-56.8
=
Enterprise Value
402.9m EUR
/
EBIT
-11.5m CAD
All Countries
Close
Market Cap EV/EBIT
CA
SNDL Inc
F:VY4
479.8m EUR -56.8
US
Eli Lilly and Co
NYSE:LLY
993.4B USD 38.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
508.5B USD 21.5
CH
Roche Holding AG
SIX:ROG
256.1B CHF 13.6
UK
AstraZeneca PLC
LSE:AZN
209.1B GBP 158.3
CH
Novartis AG
SIX:NOVN
206.4B CHF 14.8
US
Merck & Co Inc
NYSE:MRK
243.7B USD 10.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 11
IE
Endo International PLC
LSE:0Y5F
209B USD 830.4
US
Pfizer Inc
NYSE:PFE
142.5B USD 10.1
EBIT Growth EV/EBIT to Growth
CA
SNDL Inc
F:VY4
Average EV/EBIT: 1 881.1
Negative Multiple: -56.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.8
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.6
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.3
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.9
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-93.3
2-Years Forward
EV/EBIT
63.8
3-Years Forward
EV/EBIT
29.3